GRAVITY GAME HUB REVEALS RAGNAROK IDLE ADVENTURE CLOSED BETA DATE

GRAVITY GAME HUB REVEALS RAGNAROK IDLE ADVENTURE CLOSED BETA DATE

SINGAPORE, Dec. 18, 2024 /PRNewswire/ -- Gravity Game Hub (GGH) PTE.LTD, a subsidiary of GRAVITY Co., Ltd. (NasdaqGM: GRVY) has announced the start of CBT Registration for its widely anticipated AFK mobile game, Ragnarok Idle Adventure. Ragnarok...

State Grid Ningxia Electric Power Co., Ltd. Guyuan Branch helps the "ice and snow economy" in the area under Liupan Mountain

State Grid Ningxia Electric Power Co., Ltd. Guyuan Branch helps the "ice and snow economy" in the area under Liupan Mountain

GUYUAN, China, Dec. 18, 2024 /PRNewswire/ -- With the arrival of winter, Jingyuan County, located in the eastern foothills of Liupan, is actively promoting the development of its "ice and snow economy". Relying on tourism resources such as the snow...

Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

Agreement to Deliver Critical Medicines ITASCA, Ill., Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the...

ZJK Industrial Co., Ltd. Reports Financial Results for the First Six Months of Fiscal Year 2024

ZJK Industrial Co., Ltd. Reports Financial Results for the First Six Months of Fiscal Year 2024

SHENZHEN, China, Dec. 17, 2024 /PRNewswire/ -- ZJK Industrial Co., Ltd. (Nasdaq: ZJK) ("ZJK Industrial", "ZJK", or the "Company"), a high-tech enterprise specialized in the manufacturing and sale of precision fasteners, structural parts and other...

Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024

Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024

BEIJING, Dec. 17, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China's brands favored by foreigners...

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

CUPERTINO, Calif., Dec. 17, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The...

KOSE Acquires Shares of Puri Co., Ltd. in Thailand and Makes It Subsidiary

KOSE Acquires Shares of Puri Co., Ltd. in Thailand and Makes It Subsidiary

- Increasing Presence in Global South Markets and Accelerating Global Strategy - TOKYO, Dec. 16, 2024 /PRNewswire/ -- KOSE Corporation, headquartered in Chuo Ward, Tokyo and Puri Co., Ltd., headquartered in Bangkok, Thailand, which operates the...

State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company helps the development of aquaculture industry

State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company helps the development of aquaculture industry

ATUSHI, China, Dec. 13, 2024 /PRNewswire/ -- On December 11, there was a busy scene in the factory base of Kizilsu Zhanyu Aquatic Products Co., Ltd., and the staff were busy releasing fish fry into the pond to prepare for the upcoming harvest...

MGSD Announces Results for 2024 Fiscal Year

MGSD Announces Results for 2024 Fiscal Year

NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Maitong Sunshine Cultural Development Co., Ltd (OTCQB: MGSD), an enterprise that provides cultural tourism services and other related services and products, announced its financial results for the year ended...

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK,...

  • 1
  • ...
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • ...
  • 72
  • menu
    menu